| Dr Fahad Syed Gilani, MD | |
|
100 Mcgregor St, Manchester, NH 03102-3730 | |
| (603) 669-0413 | |
| (603) 663-6350 |
| Full Name | Dr Fahad Syed Gilani |
|---|---|
| Gender | Male |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 16 Years |
| Location | 100 Mcgregor St, Manchester, New Hampshire |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1184884975 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | 17506 (New Hampshire) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Catholic Medical Center | Manchester, NH | Hospital |
| St Joseph Hospital | Nashua, NH | Hospital |
| Parkland Medical Center | Derry, NH | Hospital |
| Mary Hitchcock Memorial Hospital | Lebanon, NH | Hospital |
| Lakes Region General Hospital | Laconia, NH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Catholic Medical Center | 6103897129 | 248 |
News Archive
A combination immunotherapy treatment showed better overall survival in patients with previously untreated advanced or metastatic renal cell carcinoma than current therapy, according to results from a phase 3 clinical trial presented at the Presidential Symposium of the European Society for Medical Oncology's 2017 Congress in Spain.
QRxPharma Limited announced today the US Food and Drug Administration has set 17 July 2013 as the date of the Advisory Committee meeting to consider the Company's resubmitted MOXDUO New Drug Application.
Poor diets are the now the leading risk factor for the global burden of disease, accounting for one-fifth of all deaths worldwide. While the causes of poor diets are complex, new research finds the affordability of more nutritious foods is an important factor.
Scientists from Tohoku University's Tohoku Medical Megabank Organization have published research about genetic diversity and metabolome in Scientific Reports.
› Verified 1 days ago
| Entity Name | Upper Connecticut Valley Hospital Association |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1861489437 PECOS PAC ID: 3870485923 Enrollment ID: O20040325000768 |
News Archive
A combination immunotherapy treatment showed better overall survival in patients with previously untreated advanced or metastatic renal cell carcinoma than current therapy, according to results from a phase 3 clinical trial presented at the Presidential Symposium of the European Society for Medical Oncology's 2017 Congress in Spain.
QRxPharma Limited announced today the US Food and Drug Administration has set 17 July 2013 as the date of the Advisory Committee meeting to consider the Company's resubmitted MOXDUO New Drug Application.
Poor diets are the now the leading risk factor for the global burden of disease, accounting for one-fifth of all deaths worldwide. While the causes of poor diets are complex, new research finds the affordability of more nutritious foods is an important factor.
Scientists from Tohoku University's Tohoku Medical Megabank Organization have published research about genetic diversity and metabolome in Scientific Reports.
› Verified 1 days ago
| Entity Name | Weeks Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1508819566 PECOS PAC ID: 2769461284 Enrollment ID: O20040719000284 |
News Archive
A combination immunotherapy treatment showed better overall survival in patients with previously untreated advanced or metastatic renal cell carcinoma than current therapy, according to results from a phase 3 clinical trial presented at the Presidential Symposium of the European Society for Medical Oncology's 2017 Congress in Spain.
QRxPharma Limited announced today the US Food and Drug Administration has set 17 July 2013 as the date of the Advisory Committee meeting to consider the Company's resubmitted MOXDUO New Drug Application.
Poor diets are the now the leading risk factor for the global burden of disease, accounting for one-fifth of all deaths worldwide. While the causes of poor diets are complex, new research finds the affordability of more nutritious foods is an important factor.
Scientists from Tohoku University's Tohoku Medical Megabank Organization have published research about genetic diversity and metabolome in Scientific Reports.
› Verified 1 days ago
| Entity Name | Catholic Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1386672319 PECOS PAC ID: 6103897129 Enrollment ID: O20040813000279 |
News Archive
A combination immunotherapy treatment showed better overall survival in patients with previously untreated advanced or metastatic renal cell carcinoma than current therapy, according to results from a phase 3 clinical trial presented at the Presidential Symposium of the European Society for Medical Oncology's 2017 Congress in Spain.
QRxPharma Limited announced today the US Food and Drug Administration has set 17 July 2013 as the date of the Advisory Committee meeting to consider the Company's resubmitted MOXDUO New Drug Application.
Poor diets are the now the leading risk factor for the global burden of disease, accounting for one-fifth of all deaths worldwide. While the causes of poor diets are complex, new research finds the affordability of more nutritious foods is an important factor.
Scientists from Tohoku University's Tohoku Medical Megabank Organization have published research about genetic diversity and metabolome in Scientific Reports.
› Verified 1 days ago
| Entity Name | Androscoggin Valley Hospital Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1679526644 PECOS PAC ID: 2365350725 Enrollment ID: O20040929000254 |
News Archive
A combination immunotherapy treatment showed better overall survival in patients with previously untreated advanced or metastatic renal cell carcinoma than current therapy, according to results from a phase 3 clinical trial presented at the Presidential Symposium of the European Society for Medical Oncology's 2017 Congress in Spain.
QRxPharma Limited announced today the US Food and Drug Administration has set 17 July 2013 as the date of the Advisory Committee meeting to consider the Company's resubmitted MOXDUO New Drug Application.
Poor diets are the now the leading risk factor for the global burden of disease, accounting for one-fifth of all deaths worldwide. While the causes of poor diets are complex, new research finds the affordability of more nutritious foods is an important factor.
Scientists from Tohoku University's Tohoku Medical Megabank Organization have published research about genetic diversity and metabolome in Scientific Reports.
› Verified 1 days ago
| Entity Name | Hca Health Services Of New Hampshire Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538516851 PECOS PAC ID: 3779477005 Enrollment ID: O20180403000733 |
News Archive
A combination immunotherapy treatment showed better overall survival in patients with previously untreated advanced or metastatic renal cell carcinoma than current therapy, according to results from a phase 3 clinical trial presented at the Presidential Symposium of the European Society for Medical Oncology's 2017 Congress in Spain.
QRxPharma Limited announced today the US Food and Drug Administration has set 17 July 2013 as the date of the Advisory Committee meeting to consider the Company's resubmitted MOXDUO New Drug Application.
Poor diets are the now the leading risk factor for the global burden of disease, accounting for one-fifth of all deaths worldwide. While the causes of poor diets are complex, new research finds the affordability of more nutritious foods is an important factor.
Scientists from Tohoku University's Tohoku Medical Megabank Organization have published research about genetic diversity and metabolome in Scientific Reports.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Fahad Syed Gilani, MD 100 Mcgregor St, Manchester, NH 03102-3730 Ph: (603) 669-0413 | Dr Fahad Syed Gilani, MD 100 Mcgregor St, Manchester, NH 03102-3730 Ph: (603) 669-0413 |
News Archive
A combination immunotherapy treatment showed better overall survival in patients with previously untreated advanced or metastatic renal cell carcinoma than current therapy, according to results from a phase 3 clinical trial presented at the Presidential Symposium of the European Society for Medical Oncology's 2017 Congress in Spain.
QRxPharma Limited announced today the US Food and Drug Administration has set 17 July 2013 as the date of the Advisory Committee meeting to consider the Company's resubmitted MOXDUO New Drug Application.
Poor diets are the now the leading risk factor for the global burden of disease, accounting for one-fifth of all deaths worldwide. While the causes of poor diets are complex, new research finds the affordability of more nutritious foods is an important factor.
Scientists from Tohoku University's Tohoku Medical Megabank Organization have published research about genetic diversity and metabolome in Scientific Reports.
› Verified 1 days ago
Jenny Lin, MD Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 100 Hitchcock Way, Manchester, NH 03104 Phone: 603-695-2500 | |
Dr. Douglas F. Marks Jr., M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 87 Mcgregor St, Ste 4100, Manchester, NH 03102 Phone: 603-695-2500 Fax: 603-695-2647 | |
Dr. Jose E. Lozano, M.D. Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 718 Smyth Rd, Manchester Va, Manchester, NH 03104 Phone: 603-624-4366 | |
Frances Jensen, M.D. Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 456 Union St, Manchester, NH 03103 Phone: 866-679-0381 | |
Dr. Victor Gordan, MD Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 718 Smyth Rd, Manchester, NH 03104 Phone: 603-624-4366 Fax: 603-626-6559 | |
Dr. Peter Wilson Shaw, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 100 Mcgregor St # Stb, Manchester, NH 03102 Phone: 603-663-6350 | |
Dr. Goran Broketa, MD Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 718 Smyth Rd, Manchester, NH 03104 Phone: 603-624-4366 Fax: 603-629-3217 |